The aim of this study was to determinate aberrant promoter methylation and mRNA expression of NDRG2 in PAs and to evaluate the associations between the methylation profile of gene, mRNA expression, patients’ clinical characteristics and tumor invasiveness and recurrence. Here, NDRG2 is linked to neoplasm.